KD Logo

Investing in Centessa Pharmaceuticals plc ADR (CNTA) Is Getting More Attractive

Centessa Pharmaceuticals plc ADR’s recent filing unveils that its Chief Business Officer Weinhoff Gregory M unloaded Company’s shares for reported $0.17 million on Dec 26 ’24. In the deal valued at $17.04 per share,10,000 shares were sold. As a result of this transaction, Weinhoff Gregory M now holds 183,266 shares worth roughly $3.12 million.

Then, Weinhoff Gregory M bought 10,000 shares, generating $168,000 in total proceeds.

Before that, SAHA SAURABH sold 55,000 shares. Centessa Pharmaceuticals plc ADR shares valued at $959,057 were divested by the Chief Executive Officer at a price of $17.44 per share. As a result of the transaction, SAHA SAURABH now holds 520,661 shares, worth roughly $8.86 million.

Morgan Stanley upgraded its Centessa Pharmaceuticals plc ADR [CNTA] rating to an Overweight from a an Equal-weight in a research note published on September 20, 2024; the price target was increased to $26 from $11. A number of analysts have revised their coverage, including B. Riley Securities’s analysts, who began to cover the stock in mid September with a ‘”a Buy”‘ rating. Oppenheimer began covering CNTA with “an Outperform” recommendation on July 18, 2024. Jefferies revised its rating on November 15, 2023. It rated CNTA as “a Buy” which previously was an “a Hold”.

Price Performance Review of CNTA

On Friday, Centessa Pharmaceuticals plc ADR [NASDAQ:CNTA] saw its stock fall -2.80% to $17.01. Over the last five days, the stock has lost -1.45%. Centessa Pharmaceuticals plc ADR shares have risen nearly 1.55% since the year began. Nevertheless, the stocks have risen 117.52% over the past one year. While a 52-week high of $18.97 was reached on 01/03/25, a 52-week low of $6.65 was recorded on 01/02/25. SMA at 50 days reached $16.77, while 200 days put it at $12.79.

Levels Of Support And Resistance For CNTA Stock

The 24-hour chart illustrates a support level at 16.52, which if violated will result in even more drops to 16.03. On the upside, there is a resistance level at 17.75. A further resistance level may holdings at 18.49. The Relative Strength Index (RSI) on the 14-day chart is 49.87, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.06, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 41.57%. Stochastics %K at 61.30% indicates the stock is a holding.

How much short interest is there in Centessa Pharmaceuticals plc ADR?

A steep rise in short interest was recorded in Centessa Pharmaceuticals plc ADR stocks on 2024-12-13, growing by 1.19 million shares to a total of 3.63 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 2.44 million shares. There was a rise of 32.87%, which implies that there is a positive sentiment for the stock.

Most Popular